Heart Test Laboratories Inc. Warrant (HSCSW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Heart Test Laboratories Inc. Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Heart Test Laboratories Inc. Warrant (HSCSW) has returned 67.24% so far this year and 191.32% over the past 12 months.

Based on dividend-adjusted daily data since Jun 15, 2022, HSCSW's average daily return is +12.37%, while the average monthly return is +14.42%. At this rate, your investment would double in approximately 0.4 years.

Historically, 46% of months were positive and 54% were negative. The best month was Nov 2023 with a return of +579.5%, while the worst month was Oct 2023 at -75.6%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, HSCSW closed higher 22% of trading days. The best single day was May 20, 2024 with a return of +9,900.0%, while the worst single day was May 21, 2024 at -99.1%.

Heart Test Laboratories Inc. Warrant has an annualized alpha of 577721482338348.50%, beta of 0.03, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since June 16, 2022.

• This stock participated in 285.40% of S&P 500 Index downside but only 269.91% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.03 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HSCSW ranks 81 for risk / return — in the top 81% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Heart Test Laboratories Inc. Warrant (HSCSW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Heart Test Laboratories Inc. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Heart Test Laboratories Inc. Warrant was 99.25%, occurring on Oct 11, 2024. The portfolio has not yet recovered.

The current Heart Test Laboratories Inc. Warrant drawdown is 97.07%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Heart Test Laboratories Inc. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Heart Test Laboratories Inc. Warrant is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.